GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Concord Healthcare Group Co Ltd (HKSE:02453) » Definitions » COGS-to-Revenue

Concord Healthcare Group Co (HKSE:02453) COGS-to-Revenue : 1.19 (As of Dec. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Concord Healthcare Group Co COGS-to-Revenue?

Concord Healthcare Group Co's Cost of Goods Sold for the six months ended in Dec. 2024 was HK$215.7 Mil. Its Revenue for the six months ended in Dec. 2024 was HK$180.8 Mil.

Concord Healthcare Group Co's COGS to Revenue for the six months ended in Dec. 2024 was 1.19.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Concord Healthcare Group Co's Gross Margin % for the six months ended in Dec. 2024 was -19.33%.

Concord Healthcare Group Co COGS-to-Revenue Historical Data

The historical data trend for Concord Healthcare Group Co's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Concord Healthcare Group Co COGS-to-Revenue Chart

Concord Healthcare Group Co Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24
COGS-to-Revenue
0.96 1.10 1.30 1.12 1.17

Concord Healthcare Group Co Semi-Annual Data
Dec20 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
COGS-to-Revenue Get a 7-Day Free Trial 1.17 1.12 1.12 1.16 1.19

Concord Healthcare Group Co COGS-to-Revenue Calculation

Concord Healthcare Group Co's COGS to Revenue for the fiscal year that ended in Dec. 2024 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=486.381 / 414.582
=1.17

Concord Healthcare Group Co's COGS to Revenue for the quarter that ended in Dec. 2024 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=215.726 / 180.775
=1.19

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Concord Healthcare Group Co  (HKSE:02453) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Concord Healthcare Group Co's Gross Margin % for the six months ended in Dec. 2024 is calculated as:

Gross Margin %=1 - COGS to Revenue
=1 - Cost of Goods Sold / Revenue
=1 - 215.726 / 180.775
=-19.33 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

Concord Healthcare Group Co COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Concord Healthcare Group Co's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Concord Healthcare Group Co Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Concord Healthcare Group Co Ltd (HKSE:02453) » Definitions » COGS-to-Revenue
Comparable Companies
HKSE:02373 HKSE:01515 HKSE:01830 HKSE:03309 HKSE:02219 HKSE:00708 HKSE:01526 HKSE:03886 HKSE:02522 HKSE:06639 HCA XTER:FRE SAU:4013 XTER:FME SZSE:300015 THC BSP:RDOR3 XKLS:5225 BOM:543220 UHS
Traded in Other Exchanges
N/A
Address
No. 7 Guanghua Road, Room 26A1-26A5, East Tower, Hanwei Building, Chaoyang, Beijing, CHN, 100020
Website
https://www.concordmedical.com
Concord Healthcare Group Co Ltd is a healthcare service provider in China that specializes in oncology. The company caters to both cancer patients and third-party medical institutions. It operates its own medical institutions to provide comprehensive oncology healthcare services to cancer patients using its medical professionals and advanced precision radiation therapy. It also provides medical equipment, software, and related services to third-party medical institutions. The company's revenue is generated from its hospital business and its medical equipment, software, and related services segment. Substantially all of the company's revenue is generated from the PRC.
Executives
Yang Jianyu
Ascendium Group Limited
Concord Medical Services Holdings Limited
Morgancreek Investment Holdings Limited
Zhang Bi
Shanghai Medstar Financial Leasing Company Limited
China International Capital Corporation Limited
Zhong Jin Zi Ben Yun Ying You Xian Gong Si
Zhong Jin Jia Tai Er Qi Tian Jin Gu Quan Tou Zi Ji Jin He Huo Qi Ye You Xian He Huo
Beijing Concord Medical Technology Co., Ltd.
Concord Hospital Management Group Limited
Tianjin Concord Medical Technology Co., Ltd.

Concord Healthcare Group Co Headlines

No Headlines